Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis

Abroad (travel likely)RecruitingPHASE3

Conditions

Interstitial Lung Disease With Systemic Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU Tours, Tours, France
Contact: Study coordinator (Sylvain MARCHAND ADAM) · sylvain.marchand-adam@univ-tours.fr · +33247479834

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

Systemic Sclerosis

Abroad (travel likely)RecruitingPHASE2

Ann Arbor, United States · Arlington, United States

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

Systemic Sclerosis · Diffuse Sclerosis Systemic · Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE2

Pittsburgh, United States · Pittsburgh, United States

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE2

Los Angeles, United States · San Diego, United States

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

Systemic Sclerosis With Lung Involvement · Systemic Sclerosis · Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE2

Montreal, Canada · Montreal, Canada